Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Tevogen Bio Holdings Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Tevogen Bio Holdings Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/18/2025 | Buy Now | — | D. Boral Capital | Jason Kolbert54% | $10 → $10 | Maintains | Buy | Get Alert |
06/10/2025 | Buy Now | — | D. Boral Capital | Jason Kolbert54% | $10 → $10 | Maintains | Buy | Get Alert |
05/27/2025 | Buy Now | — | D. Boral Capital | Jason Kolbert54% | $10 → $10 | Maintains | Buy | Get Alert |
05/12/2025 | Buy Now | — | D. Boral Capital | Jason Kolbert54% | $10 → $10 | Maintains | Buy | Get Alert |
04/29/2025 | Buy Now | — | D. Boral Capital | Jason Kolbert54% | $10 → $10 | Maintains | Buy | Get Alert |
04/21/2025 | Buy Now | — | D. Boral Capital | Jason Kolbert54% | $10 → $10 | Maintains | Buy | Get Alert |
03/11/2025 | Buy Now | — | D. Boral Capital | Jason Kolbert54% | $10 → $10 | Maintains | Buy | Get Alert |
03/04/2025 | Buy Now | — | D. Boral Capital | Jason Kolbert54% | → $10 | Initiates | → Buy | Get Alert |
The latest price target for Tevogen Bio Holdings (NASDAQ:TVGN) was reported by D. Boral Capital on June 18, 2025. The analyst firm set a price target for $10.00 expecting TVGN to rise to within 12 months (a possible 733.33% upside). 8 analyst firms have reported ratings in the last year.
The latest analyst rating for Tevogen Bio Holdings (NASDAQ:TVGN) was provided by D. Boral Capital, and Tevogen Bio Holdings maintained their buy rating.
There is no last upgrade for Tevogen Bio Holdings
There is no last downgrade for Tevogen Bio Holdings.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tevogen Bio Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tevogen Bio Holdings was filed on June 18, 2025 so you should expect the next rating to be made available sometime around June 18, 2026.
While ratings are subjective and will change, the latest Tevogen Bio Holdings (TVGN) rating was a maintained with a price target of $10.00 to $10.00. The current price Tevogen Bio Holdings (TVGN) is trading at is $1.20, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.